- Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
- Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Enovis Announces Fourth Quarter and Full Year 2023 Results
- Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
- Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
- Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
- Enovis Introduces the DonJoy ROAM™ OA Knee Brace
- Enovis finalise l’acquisition de LimaCorporate S.p.A.
- エノビス (Enovis) がリマ・コーポレート (LimaCorporate S.p.A) の買収を完了
More ▼
Key statistics
On Tuesday, Enovis Corp (C520:DUS) closed at 51.50, 1.98% above its post-IPO low of 50.50, set on Apr 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 51.00 |
---|---|
High | 51.50 |
Low | 51.00 |
Bid | 51.00 |
Offer | 52.50 |
Previous close | 51.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 54.84m |
Free float | 51.70m |
P/E (TTM) | -- |
Market cap | 3.07bn USD |
EPS (TTM) | -0.9987 USD |
Data delayed at least 15 minutes, as of Apr 30 2024 18:31 BST.
More ▼